Daniel J. Moore, MD, PhD
Dr. Moore's research program focuses on the pathogenesis of Type 1 diabetes and identifying new approaches to prevent and cure disease. His research progress is primarily focused on the immunology of diabetes including identifying novel mechanisms by which the immune-mediated destruction of islet beta cells can be prevented. Additional research focuses on the potential of islet transplantation as a permanent treatment for T1D. In addition to his basic science work, he is also leading translational and clinical research in T1D including using MRI to study the pancreas in T1D and trials to study immune therapies for T1D.
Type 1 diabetes, autoimmune thyroid disease, autoimmune endocrinopathies
Specialty
Endocrinology, Pediatric
Ph.D.
University of Pennsylvania, Philadelphia, PA, 2003
M.D.
University of Pennsylvania, Philadephia, PA, 2004
Internship
Pediatrics Internship-Vanderbilt University Medical Center, Nashville, TN
Residency
Pediatrics Residency-Vanderbilt University Medical Center, Nashville, TN
Fellowship
Pediatrics Endocrinology Fellowship-Vanderbilt University Medical Center, Nashville, TN
Jefferson P. Lomenick, MD
Diabetes, growth, thyroid, adrenal
Specialty
Endocrinology, Pediatric
M.D.
Vanderbilt University School of Medicine, Nashville, TN, 1998
Residency
Pediatric Residency-University of Virginia Health Sciences Center, Charlottesville, VA
Fellowship
Pediatric Endocrinology Fellowship-Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Yaa A. Kumah-Crystal, MD, MPH
M.D.
Vanderbilt University, 2008
Fellowship
Vanderbilt University Medical Center, 2014
Residency
Vanderbilt University Medical Center, 2011
M.A.
Johns Hopkins University, 2004
M.P.H.
Vanderbilt University, 2014
Jennifer Kelley, MD, MSCE
Dr. Kelley's studies have included examinations of longitudinal changes in bone and body composition in obese adolescents undergoing weight loss as well as in newly diagnosed children with type 1 diabetes. She has also conducted studies evaluating lipid abnormalities in high risk pediatric populations. Dr. Kelley's clinical and research interests within lipidology include familial hypercholesterolemia, hypertriglyceridemia and abnormal lipoprotein(a) in children. She is currently a local principal investigator for clinical trials, including use of PCSK-9 inhibitors in children with familial hypercholesterolemia. She also is a local principal investigator in the Type 1 Diabetes Exchange, a multi-institutional collaboration to improve the lives and care of patients with type 1 diabetes.
Type 1 diabetes mellitus, Type 2 diabetes mellitus, Maturity onset diabetes of the young (MODY), Lipid disorders, Growth disorders, Disorders of puberty, Thyroid disorders, Pituitary disorders, Adrenal disorders
Specialty
Endocrinology, Pediatric
M.D.
University of Cincinnati College of Medicine, Cincinnati, OH, 2009
Residency
Pediatric Residency-Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Fellowship
Pediatric Endocrinology Fellowship-Children's Hospital at Philadelphia, PA
M.S.C.E
Master of Science in Clinical Epidemiology, University of Pennsylvania, Philadelphia, PA, 2019
Sarah Jaser, PhD
Dr. Jaser studies risk and protective factors in children and adolescents with type 1 diabetes. She has demonstrated the effects of adolescent coping, maternal adjustment, and parenting on adolescents' glycemic control and quality of life. She is currently developing and testing interventions to improve outcomes in youth with diabetes and their families. These include a program to help mothers cope effectively with the stress of parenting adolescents with type 1 diabetes, a positive psychology intervention to improve adolescents adherence, and sleep-promoting programs for children and adolescents with type 1 diabetes. In addition, she is interested in neurocognitive complications in pediatric type 1 diabetes.
Pediatric Diabetes
Specialty
Endocrinology, Pediatric
M.S.
Vanderbilt University , Nashville, TN, 2003
Ph.D.
Vanderbilt University, Nashville, TN, 2006
Irene Hong-McAtee, MD, MS
Pediatric Type 1 diabetes mellitus; Pediatric Type 2 diabetes mellitus; Diabetes insipidus; Congenital Hypothyroidism; Hashimoto's Hypothyroidism; Central hypothyroidism; Precocious Puberty; Delayed Puberty; Panhypopituitarism
Specialty
Endocrinology, Pediatric
M.D.
Washington University School of Medicine, St. Louis, MO, 1999
M.S.
School of Public Health, University of Minnesota, Twin Cities, MN, 2006
Residencies
Pediatric Residency-Indiana University School of Medicine, Indianapolis, IN
Pediatric Chief Resident-Indiana University School of Medicine, Indianapolis, IN
Fellowship
Pediatric Endocrinology Fellowship-University of Minnesota Medical School, Twin Cities, MN